Interstitial lung diseases (ILDs) refer to a heterogeneous and complex group of conditions characterized by inflammation, fibrosis, or both, in the interstitium of the lungs. This results in impaired gas exchange, leading to a worsening of respiratory symptoms and a …

In patients with ILD, exercise training improves 6-minute walk test distance and quality of life. This review summarizes current evidence regarding the diagnosis and treatment of interstitial lung disease.

Interstitial lung disease (ILD) is an umbrella term for over 200 different diseases that display considerable variation in terms of clinical course, treatment and prognosis. Broadly speaking, they can be subdivided into those with an identifiable cause and those without; the latter being referred to as idiopathic interstitial pneumonias.

• The most common ILDs are sarcoidosis, CTD-ILD and IPF, with prevalence of 30.2, 12.1 and 8.3 per 100,000. Respectively; prevalence varies widely between age ranges. • Almost 13-40% of all non-IPF ILD cases will develop a progressive fibrosing phenotype, accounting for 28 patients in the USA and 20 patients in Europe per 100,000.

ILD can be seen in all CTDs but most commonly in rheumatoid arthritis (RA), systemic sclerosis (SSc), and idiopathic inflammatory myopathy (IIM). This primer will focus on the general features of CTD-ILDs along with distinct features noted in RA, SSc, and IIM-associated ILD.

The diffuse parenchymal lung diseases, often collectively referred to as the interstitial lung diseases (ILDs), are a heterogeneous group of disorders that are classified together because of similar clinical, radiographic, physiologic, or pathologic manifestations (algorithm 1) [1-7].

2013年12月13日 · This review reports the relevant progress in the field of interstitial lung disease (ILD) (table 1), as reviewed during the Clinical Year in Review session that was presented at the 2013 European Respiratory Society (ERS) Annual Congress in Barcelona, Spain.

2020年6月29日 · Interstitial lung disease (ILD): umbrella term for conditions affecting the lung interstitium. Mortality: particularly high in idiopathic pulmonary fibrosis (median survival 4 years). Pathophysiology : inflammation and fibrosis in lung interstitium; fibrosis increases diffusion distance for oxygen, compromising gas exchange.

Interstitial lung disease (ILD) is a broad and complex heterogeneous group of lung diseases. While clinical practice guidelines (CPG) have been developed for the diagnosis and management of idiopathic pulmonary fibrosis (IPF), CPG for the diagnosis and management of patients with other ILD are lacking.

Owing to a variety of clinical presentations, as well as overlapping imaging and histopathologic findings (Table 287-1), ILDs can be difficult to diagnose. A generally accepted central tenet of ILD diagnosis is that the combined weight of clinical data, laboratory studies, pulmonary function testing, imaging findings, and histopathology (if ...